Home › Products › Infectious Disease › Prevenar 13 Vaccine
Prevenar 13 Vaccine
Salt Composition: PNEUMOCOCCAL VACCINE
- Manufacturer: PFIZER LTD
- Pack Size: 1 PREFILLED SYRINGE(s) OF 0.5ML
- Dosage Form: INJECTION
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Keep the pneumococcal vaccine Prevenar 13 out of the sight and reach of children. Store in a refrigerator (2°C to 8°C). Do not freeze.
₹3192.00₹3991.05
Inclusive of all taxes
Product Introduction
Prevenar 13 is a pneumococcal conjugate vaccine indicated for protection against infections caused by Streptococcus pneumoniae in children aged 6 weeks to 17 years and in adults. The vaccine helps prevent serious conditions including meningitis, sepsis, bacteremia, pneumonia, and otitis media by stimulating the body to produce antibodies against 13 different pneumococcal serotypes. Prevenar 13 is administered according to an age-specific schedule with primary doses followed by a booster dose to maintain immunity. Patients and healthcare providers may consider alternative pneumococcal vaccines such as Synflorix, Pneumosil, and Pneumovax 23 when selecting an appropriate vaccine based on age group and clinical requirements. Prevenar 13 pricing varies across different pharmacies and healthcare facilities. Safety and effectiveness data support its use in paediatric and adult vaccination programmes to provide protection against multiple pneumococcal infections.
Uses
Prevenar 13 uses are in the treatment of the following: Meningitis Pneumonia Sepsis or bacteremia Ear infection
How it works
Prevenar 13 Vaccine triggers the immune system to produce more antibodies that protect against infections.
Side Effects
Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them. Prevenar 13 side effects are Serious Difficulty in breathing Blue discoloration of lips or tongue Dizziness Fever Joint swelling Muscle pain Swelling of lips, tongue, throat, neck, hand, feet, or ankles Skin hives and rashes Common Swelling and hardening at the injection site Soreness Pain Redness
References
- Merck Sharp & Dohme (UK) Limited, Electronic medicines compendium (EMC), [Revised on November 2022] [Accessed on 16th May 2023], Pneumovax 23 solution for injection in pre-filled syringe - Patient Information Leaflet (PIL) - (emc) (medicines.org.uk)
- Drug.com, [Accessed on 16th May 2023], https://www.drugs.com/history/prevnar-20.html
- U.S. Department of Health and Human Services, vaccine information statement, [Accessed on 16th May 2023], https://www.cdc.gov/vaccines/hcp/vis/vis-statements/pcv.pdf
Safety Advice
Pregnancy: Consult your doctor Inform your medical profession if you are pregnant or think you may be pregnant, or are planning to have a baby or breastfeeding. Ask for the suggestion before taking Prevenar 13 Vaccine.
Lungs: Consult your doctor It is unknown whether Prevenar 13 Vaccine is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms
Breastfeeding: Consult your doctor It is unknown whether the ingredient of Prevenar 13 Vaccine passes to the breast milk. Inform your doctor to get advice regarding breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.